Indicators for the Metabolic Syndrome as Well as the Influence of Different Gen-polymorphs on Weightloss and the Maintenance of Lower Weight Among Children in Treatment for Overweight
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Childhood Obesity
- Sponsor
- Holbaek Sygehus
- Enrollment
- 517
- Locations
- 1
- Primary Endpoint
- weightloss
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
Definition:
the overall objective is to examine childhood obesity with focus on NAFLD and its treatment. Further, we aimed to investigate the impact of genetic variation on obesity.
The specific aims are to;
- describe the degree of NAFLD among overweight and obese, Danish children. (hypothesis; the degree for pediatric NAFLD among Danish Children was equal that found in other Caucasian paediatric study populations).
- investigate the effect of a multidisciplinary intervention treatment of 1 year on liver fat content.
(hypothesis; the intervention could reduce the liver fat percentage and a reduction in BMI SDS would associate with a reduction in liver fat content) - Analyze changes in liver fat content in relation to changes in levels of fasting blood variables to see if any of them could be used as a clinical tool for monitoring hepatic steatosis in the clinic.
(hypothesis; serum aminotransferases (separately and their ratio, respectively), serum insulin, and HOMA-IR could predict improvement in liver fat content
- Investigate the association between genetic variants and obesity.
Investigators
Jens-Christian Holm
MD, Ph.D.
Zealand University Hospital
Eligibility Criteria
Inclusion Criteria
- •5- 20 Years old.
- •Adipose. BMI \> 90 % percentile
- •New patient in the Children's Obesity Clinic, Paediatric Department, University Hospital Holbaek,Region Zealand, Denmark
- •Informed Consent
Exclusion Criteria
- •Drop-outs
Outcomes
Primary Outcomes
weightloss
Time Frame: 1 Year
Secondary Outcomes
- NAFLD (non-alcoholic Fatty Liver Disease).Gene-polymorphs(1 Year)